Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized dexmedetomidine versus nebulized lidocaine versus saline before pediatric fiberoptic bronchoscopy
IRCT20160301026866N9Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine, lidocaine and saline in bronchitis (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Hemodynamic changes, Systolic blood pressure and 3 more. Started Sep 2018; status: completed.
02
Drugs
dexmedetomidinelidocainesaline
03
Conditions
bronchitis
Beyond the preview
Go deeper on IRCT20160301026866N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160301026866N9.